PhySH "Physician Scientist Hour"

INDE 217 : Physician Scientist Hour (PhySH)
Mondays at 12:15pm - 1:15pm

Please register for PhySH - INDE 217
(You are not required to register to attend.)

You might also be interested in the TRAM lecture series, which hosts speakers who are recognized leaders in translational research and applied medicine.  Please see the Translational Research and Applied Medicine website for more information.

Autumn 2022 PhySH Schedule

We will provide updates as information becomes available.

Justin Annes
September 26,  2022
Opportunities for the physician scientists in endocrin(onc)ology: From animal disease models to drug development
The Annes Lab specializes in the treatment of hereditary endocrine disorders with particular focus on neuroendocrine-related conditions. The lab’s goal is to develop novel therapeutic strategies for diabetes and neuroendocrine tumors. In the laboratory they have developed a variety of animal models, including the first SDHB-deficient hPGL mouse , and  new chemical strategies for neuroendocrine cell-targeted drug delivery.

Choosing Rotation Labs - Student Panel
October 3, 2023

Charlotte Herber - G3 Research Talk
October 10, 2022 

Chrystal Botham - Grant Writing Academy
October 17,  2022
Fundamentals of the NIH grants process
Dr. Crystal Botham is the inaugural director of the Stanford Biosciences Grant Writing Academy & Office of Pediatric Research Development. The Grant Writing Academy (founded in 2014) aims to center joy and belonging in grant writing and beyond. A core program is an intensive 8-week Proposal Bootcamp, which was honored with an Innovations in Research Education Award from the Association of American Medical Colleges. The Bootcamp supports grant writers (graduate students, postdocs, faculty, etc.) through weekly meetings with trained Grant Coaches to impart grantspersonship skills and conduct peer review.

Laura Attardi
October 24, 2022
Deconstructing cancer  development through a p53 lens
The Attardi Lab seeks to better define the mechanisms by which the p53 transcription factor directs tumor suppressive responses in vivo, with the ultimate goal of gaining insight that will facilitate clinical advances in diagnosis, prognostication and therapy. The lab has a particular emphasis on understanding how p53 blocks lung and pancreatic cancer, two especially deadly cancers, by focusing on how p53 affects tumor initiation and evolution as well as crosstalk between cancer cells and cells of the tumor microenvironment. Notably, there is not yet a standard-of-care therapy for cancer based on targeting the p53 pathway, and the lab strives to change this by using a combination of mouse genetic, cell biological, biochemical, and single cell genomic approaches to address understand how p53 acts mechanistically in vivo and by developing new therapeutic approaches in mouse models.

Sean Wu
October 31, 2022
Science at the crossroads of development, stem cells, and machine learning
The Wu lab is dedicated to the identification of molecular mechanisms regulating heart development using genetically-targeted mice in vivo and pluripotent stem cell-derived cardiac cells in vitro. In addition, his lab employs bioengineering approaches to generate cardiac tissues for regenerate medicine applications.

Barbara Erny (RCR - Environment Talk)
November 7, 2022
The climate crisis: Health, equity, and how you can make healthcare sustainable
As an Adjunct Clinical Associate Professor at Stanford University School of Medicine, Dr. Erny lectures to physicians, students and the community, and mentors students on climate change and health/equity. She is a founding member of the Stanford Task Force for Climate, Health and Equity and is the Director of Education, leading efforts to integrate climate change education into medical school curricula and all levels of physician training.

Olivia Zhou - G3 Research Talk
November 15, 2022

MSTP Town Hall
November 28, 2022